Akero Therapeutics Financial Overview
Akero Therapeutics's market cap is currently $4.50B. The company's EPS TTM is $-0.9; its P/E ratio is ―; Akero Therapeutics is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.92. See an overview of income statement, balance sheet, and cash flow financials.
